Literature DB >> 10358149

IL-7 up-regulates IL-4 production by splenic NK1.1+ and NK1.1- MHC class I-like/CD1-dependent CD4+ T cells.

A Hameg1, C Gouarin, J M Gombert, S Hong, L Van Kaer, J F Bach, A Herbelin.   

Abstract

NK T cells are an unusual subset of T lymphocytes. They express NK1. 1 Ag, are CD1 restricted, and highly skewed toward Vbeta8 for their TCR usage. They express the unique potential to produce large amounts of IL-4 and IFN-gamma immediately upon TCR cross-linking. We previously showed in the thymus that the NK T subset requires IL-7 for its functional maturation. In this study, we analyzed whether IL-7 was capable of regulating the production of IL-4 and IFN-gamma by the discrete NK T subset of CD4+ cells in the periphery. Two hours after injection of IL-7 into mice, or after a 4-h exposure to IL-7 in vitro, IL-4 production by CD4+ cells in response to anti-TCR-alphabeta is markedly increased. In contrast, IFN-gamma production remains essentially unchanged. In beta2-microglobulin- and CD1-deficient mice, which lack NK T cells, IL-7 treatment does not reestablish normal levels of IL-4 by CD4+ T cells. Moreover, we observe that in wild-type mice, the memory phenotype (CD62L-CD44+) CD4+ T cells responsible for IL-4 production are not only NK1.1+ cells, but also NK1.1- cells. This NK1.1-IL-4-producing subset shares three important characteristics with NK T cells: 1) Vbeta8 skewing; 2) CD1 restriction as demonstrated by their absence in CD1-deficient mice and relative overexpression in MHC II null mice; 3) sensitivity to IL-7 in terms of IL-4 production. In conclusion, the present study provides evidence that CD4+MHC class I-like-dependent T cell populations include not only NK1.1+ cells, but also NK1.1- cells, and that these two subsets are biased toward IL-4 production by IL-7.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10358149

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

Review 1.  Current status and challenges of cytokine pharmacology.

Authors:  Z Zídek; P Anzenbacher; E Kmonícková
Journal:  Br J Pharmacol       Date:  2009-04-03       Impact factor: 8.739

2.  Graft-versus-host disease in recipients of grafts from natural killer T cell-deficient (Jalpha281(-/-)) donors.

Authors:  Cynthia A Ellison; Masaru Taniguchi; Jacqie M M Fischer; Kent T Hayglass; John G Gartner
Journal:  Immunology       Date:  2006-07-26       Impact factor: 7.397

Review 3.  Role of interleukin-18 in the pathophysiology of allergic diseases.

Authors:  Nathan L Sanders; Anil Mishra
Journal:  Cytokine Growth Factor Rev       Date:  2016-07-15       Impact factor: 7.638

4.  T-cell apoptosis and differential human leucocyte antigen class II expression in human thymus.

Authors:  D C Douek; D M Altmann
Journal:  Immunology       Date:  2000-02       Impact factor: 7.397

5.  Interleukin (IL)-4 promotes T helper type 2-biased natural killer T (NKT) cell expansion, which is regulated by NKT cell-derived interferon-gamma and IL-4.

Authors:  Akira Iizuka; Yoshinori Ikarashi; Mitsuzi Yoshida; Yuji Heike; Kazuyoshi Takeda; Gary Quinn; Hiro Wakasugi; Masanobu Kitagawa; Yoichi Takaue
Journal:  Immunology       Date:  2007-11-14       Impact factor: 7.397

6.  Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis.

Authors:  A K Singh; M T Wilson; S Hong; D Olivares-Villagómez; C Du; A K Stanic; S Joyce; S Sriram; Y Koezuka; L Van Kaer
Journal:  J Exp Med       Date:  2001-12-17       Impact factor: 14.307

7.  A natural killer T (NKT) cell developmental pathway iInvolving a thymus-dependent NK1.1(-)CD4(+) CD1d-dependent precursor stage.

Authors:  Daniel G Pellicci; Kirsten J L Hammond; Adam P Uldrich; Alan G Baxter; Mark J Smyth; Dale I Godfrey
Journal:  J Exp Med       Date:  2002-04-01       Impact factor: 14.307

8.  Interleukin-7 protects against bacterial respiratory infection by promoting IL-17A-producing innate T-cell response.

Authors:  Maya Hassane; Youenn Jouan; Florent Creusat; Daphnée Soulard; Chloé Boisseau; Loïc Gonzalez; Emmanuel C Patin; Nathalie Heuzé-Vourc'h; Jean-Claude Sirard; Christelle Faveeuw; François Trottein; Mustapha Si-Tahar; Thomas Baranek; Christophe Paget
Journal:  Mucosal Immunol       Date:  2019-10-18       Impact factor: 7.313

9.  Mouse V alpha 14i natural killer T cells are resistant to cytokine polarization in vivo.

Authors:  Jennifer L Matsuda; Laurent Gapin; Jody L Baron; Stéphane Sidobre; Daniel B Stetson; Markus Mohrs; Richard M Locksley; Mitchell Kronenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-26       Impact factor: 12.779

10.  A critical role for natural killer T cells in immunosurveillance of methylcholanthrene-induced sarcomas.

Authors:  Nadine Y Crowe; Mark J Smyth; Dale I Godfrey
Journal:  J Exp Med       Date:  2002-07-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.